M84.574 Pathological fracture in neoplastic disease, right foot

Name of the Condition

• Pathological Fracture in Neoplastic Disease, Right Foot (ICD-10-CM: M84.574)

Summary

This condition describes a bone fracture occurring due to underlying neoplastic (cancerous) disease, specifically involving the right foot. The fracture results from weakened bone structure caused by the presence of cancer, rather than direct trauma. It is a complication of malignancy affecting the right foot's bone integrity, which may involve primary bone tumors or metastatic spread to these regions.

Causes

Pathological fractures in neoplastic disease arise when cancerous growths infiltrate or destroy bone tissue in the right foot, compromising its structural strength. Primary bone cancers (e.g., osteosarcoma) or metastatic tumors (e.g., from breast, lung, or prostate cancer) can erode bone in the foot, leading to spontaneous or minimal-force fractures. Tumor-induced bone destruction or treatment-related effects (e.g., radiation therapy) may also contribute to the weakened bone.

Risk Factors

• History of cancer, particularly with known bone metastasis to the foot.
• Advanced-stage malignancies with skeletal involvement.
• Tumors that preferentially affect bone (e.g., multiple myeloma).
• Prior radiation therapy to foot sites.
• Systemic therapies that weaken bone (e.g., certain chemotherapies).

Symptoms

• Sudden onset of pain at the right foot, often without significant trauma.
• Swelling, bruising, or deformity in the affected area.
• Difficulty bearing weight or walking.
• Limited range of motion in the foot or ankle.
• Possible numbness or tingling if nerves are affected.

Diagnosis

Diagnosis involves a combination of clinical evaluation, imaging, and laboratory tests. A healthcare provider will assess symptoms and medical history, followed by imaging (e.g., X-rays, MRI, or CT scans) to identify the fracture and underlying neoplastic disease. Biopsy or bone scans may be used to confirm cancer involvement. Blood tests or other studies may help determine the type and extent of malignancy.

Treatment Options

Treatment focuses on stabilizing the fracture, managing pain, and addressing the underlying cancer. Options may include immobilization (e.g., casting or bracing), pain management, and cancer-specific therapies (e.g., chemotherapy, radiation, or surgery). Orthopedic intervention (e.g., fixation) may be necessary for severe fractures. Multidisciplinary care involving oncologists and orthopedic specialists is often required.

Prognosis and Follow-Up

Prognosis depends on the type and stage of the underlying cancer, as well as the fracture's severity. Early detection and treatment of the malignancy improve outcomes. Follow-up care includes monitoring for fracture healing, cancer progression, and potential complications. Regular imaging and clinical assessments are typically recommended.

Complications

• Delayed or nonunion of the fracture.
• Infection at the fracture site.
• Nerve damage or vascular compromise.
• Progression of the underlying cancer.
• Chronic pain or functional impairment.

Lifestyle & Prevention

• Maintain bone health through adequate nutrition (e.g., calcium, vitamin D) and weight-bearing exercise, if appropriate.
• Avoid high-impact activities that may increase fracture risk.
• Follow cancer treatment plans as prescribed to manage underlying disease.
• Use supportive footwear or orthotics to reduce stress on the foot.

When to Seek Professional Help

Seek immediate medical attention if you experience sudden, severe foot pain, swelling, or inability to bear weight, especially if you have a history of cancer. Prompt evaluation is critical to address the fracture and underlying malignancy.

Tips for Medical Coders

Document the anatomical specificity (right foot) and confirm the fracture is pathological (due to neoplastic disease) rather than traumatic. Ensure clinical documentation supports the diagnosis and links the fracture to the underlying cancer. Code M84.574 is specific to the right foot; verify no other codes are needed for the neoplastic disease itself unless separately documented.